Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-15 Option Award |
2025-04-16 4:30 pm |
N/A 2035-04-14 |
Xilio Therapeutics Inc. | XLO | Russo Rene PRESIDENT AND CEO |
190,000 | $0 | 190,000 (Direct) |
View |
| 2025-01-01 Option Award |
2025-01-03 4:15 pm |
N/A 2035-12-31 |
Xilio Therapeutics Inc. | XLO | Russo Rene PRESIDENT AND CEO |
638,000 | $0 | 1,015,633 (Direct) |
View |
| 2025-01-01 Exercise |
2025-01-03 4:15 pm |
N/A N/A |
Xilio Therapeutics Inc. | XLO | Russo Rene PRESIDENT AND CEO |
44,250 | $0 | 1,015,633 (Direct) |
View |
| 2024-05-01 Option Award |
2024-05-03 4:10 pm |
N/A 2034-04-30 |
Xilio Therapeutics Inc. | XLO | Russo Rene PRESIDENT AND CEO |
474,000 | $0 | 474,000 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-03 4:15 pm |
N/A N/A |
Xilio Therapeutics Inc. | XLO | Russo Rene PRESIDENT AND CEO |
177,000 | $0 | 177,000 (Direct) |
View |
| 2023-08-16 Option Award |
2023-08-18 8:45 pm |
N/A 2033-08-15 |
Xilio Therapeutics Inc. | XLO | Russo Rene CEO |
700,000 | $0 | 700,000 (Direct) |
View |
| 2023-01-01 Option Award |
2023-01-04 4:14 pm |
N/A 2032-12-31 |
Xilio Therapeutics Inc. | XLO | Russo Rene CEO |
350,000 | $0 | 350,000 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 5:30 pm |
N/A 2032-02-21 |
Xilio Therapeutics Inc. | XLO | Russo Rene CEO AND PRESIDENT |
150,000 | $0 | 150,000 (Direct) |
View |
| 2021-12-22 Option Award(A) |
2022-01-04 5:32 pm |
N/A 2031-12-21 |
Xilio Therapeutics Inc. | XLO | Russo Rene CEO AND PRESIDENT |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-12-22 Option Award |
2021-12-23 7:06 pm |
N/A 2031-12-21 |
Xilio Therapeutics Inc. | XLO | Russo Rene CEO AND PRESIDENT |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-10-21 Option Award |
2021-10-25 5:18 pm |
N/A 2031-10-20 |
Xilio Therapeutics Inc. | XLO | Russo Rene CEO and President 10% Owner |
50,041 | $0 | 50,041 (Direct) |
View |
Ownership |
2021-10-21 8:45 pm |
N/A N/A |
Xilio Therapeutics Inc. | XLO | Russo Rene CEO and President 10% Owner |
0 | $0 | 1,048,804 (Direct) |
View |
| 2021-08-05 Option Award |
2021-08-09 7:55 pm |
N/A 2031-08-04 |
Adagio Therapeutics Inc. | ADGI | Russo Rene Director |
35,593 | $0 | 35,593 (Direct) |
View |
Ownership |
2021-08-05 9:26 pm |
N/A N/A |
Adagio Therapeutics Inc. | ADGI | Russo Rene Director |
0 | $0 | 1,985,295 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-02 4:57 pm |
N/A 2031-06-02 |
X4 Pharmaceuticals Inc | XFOR | Russo Rene Director |
6,000 | $9.5 | 6,000 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-11 08:31 am |
N/A 2030-06-09 |
X4 Pharmaceuticals Inc | XFOR | Russo Rene Director |
3,427 | $0 | 3,427 (Direct) |
View |